Prognostic Significance of the Lymphoblastic Leukemia-Derived Sequence 1 (LYL1) Gene Expression in Egyptian Patients with Acute Myeloid Leukemia by Nadia El Menshawy, Doaa Shahin, Hayam Fathi Ghazi

Subjects: Get full text

Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders by Argiris Symeonidis, Spiros Chondropoulos, Evgenia Verigou, Vasileios Lazaris, Alexandra Kourakli, Panagiotis Tsirigotis

Subjects: Get full text

7.341 Bench to Bedside: Molecularly Targeted Therapies in Blood Disorders and Malignancy, Fall 2009 by Flygare, Johan, Wong, Bill

Subjects: Get full text

7.342 Personal Genomics and Medicine: What's in Your Genome?, Spring 2014 by Herskovits, A. Zara

Subjects: Get full text

Management of patients with hematological malignancies undergoing coronary artery bypass grafting by Deepak Borde, Uday Gandhe, Neha Hargave, Kaushal Pandey

Subjects: Get full text

A patient with maculopapular rash and lichenoid skin damage caused by ponatinib by Ingrid Anna Teigen, Anna Kristine Myrmel Sæle, Håkon Reikvam

“…This is important considerting the limited alternative treatment approaches available for BCR-ABL1 T315I chronic myelogenous leukemia.…”
Get full text

Anti-Cancer Effects of Oxygen-Atom-Modified Derivatives of Wasabi Components on Human Leukemia Cells by Jui-Feng Lin, Chih-Wen Chi, Yu-Chuen Huang, Tung-Hu Tsai, Yu-Jen Chen

“…We previously demonstrated that extensive mitotic arrest, spindle multipolarity, and cytoplasmic vacuole accumulation were induced by 6-MITC and inhibited the viability of human chronic myelogenous leukemia K562 cells. In this study, we examined the anti-cancer effects of 6-MITC derivatives on human chronic myelogenous leukemia (CML) cells. …”
Get full text

Induction of Apoptosis, G0/G1 Phase Arrest and Microtubule Disassembly in K562 Leukemia Cells by Mere15, a Novel Polypeptide from Meretrix meretrix Linnaeus by Xiukun Lin, Ning Wu, Linyou Cheng, Jin Zhao, Haizhou Liu, Lin Xiao, Cuicui Wang, Xiangzhong Zhao, Ming Liu

“…In this study, we investigated its activity on human K562 chronic myelogenous leukemia cells. Mere15 inhibited the growth of K562 cells with IC50 values of 38.2 μg/mL. …”
Get full text

Hemo-Lymphopoietic Malignancies Surround the Women of the Family: A Case Report and Literature Review by Behjat Kalantari-Khandani, Ali Akbar Haghdoost, Mohsen Momeni, Mina Danaei

“…Case 2 and 3 presented with chronic myelogenous leukemia at age 32 and diffuse large B-cell lymphoma at age 28, respectively. …”
Get full text

Transcriptome sequencing of hematopoietic stem cells and chronic myelgenous leukemia stem cells by Junil Kim, Seong-Jin Kim, Kazuhito Naka

“…Keywords: Chronic myelogenous leukemia, CML stem cell, Dipeptide transporter, RNA sequencing, Slc15a2…”
Get full text

Generalized granuloma annulare associated with essential thrombocythemia by Sai P. Polineni, Steven Lawyer

“…Abstract The only myeloproliferative neoplasm associated with generalized granuloma annulare (GA) is chronic myelogenous leukemia (CML). We present the first reported case of GA in a patient with essential thrombocythemia (ET). …”
Get full text

A New Cytotoxic Pregnanone from Calotropis gigantea by Mao-Yuan Wang, Zhu-Nian Wang, Wen-Li Mei, Zhuang Han, Hao-Fu Dai

“…Compounds 1 and 2 displayed inhibitory effects towards chronic myelogenous leukemia K562 and human gastric cancer SGC-7901 cell lines.…”
Get full text

Blast crisis of chronic myeloid leukemia initially presenting as severe acute intracerebral hemorrhage by Shri Ram Sharma, Biswajit Dey

“…Intracerebral hemorrhage is a leading cause of mortality among patients diagnosed with chronic myelogenous leukemia (CML). In this report we discussed the case of a previously healthy male patient, who presented with fatal ICH, newly diagnosed with blast crisis in CML.…”
Get full text

A New Hydroxylated Nonaprenylhydroquinone from the Mediterranean Marine Sponge Sarcotragus spinosulus by Mohamed Mehiri, Guillaume Robert, Vincent Guérineau, Jean Vacelet, Philippe Amade, Patrick Auberger, Maeva Dufies, Charline Abed, Nathalie Legrave

“…The antileukemic effect of the three compounds towards the chronic myelogenous leukemia (CML) cells line K562 was also evaluated.…”
Get full text

Study of the behaviour of proliferating cells in leukemia modelled by a system of delay differential equations by Ion Anca Veronica

“…For the model of periodic chronic myelogenous leukemia considered by Pujo-Menjouet, Mackey et al., model consisting of two delay differential equations, the equation for the density of so-called “resting cells” was studied from numerical and qualitative point of view in several works. …”
Get full text

AS1041, a Novel Synthesized Derivative of Marine Natural Compound Aspergiolide A, Arrests Cell Cycle, Induces Apoptosis, and Inhibits ERK Activation in K562 Cells by Fengli Yuan, Liang Qiao, Yinghan Chen, Xin Qi, Yankai Liu, Dehai Li, Qianqun Gu, Jing Li, Ming Liu

“…To study its cytotoxicity in detail, we evaluated its activity on human K562 chronic myelogenous leukemia cells and investigated the related molecule mechanisms. …”
Get full text

Red blood cell distribution width at diagnosis as a predictor factor in chronic phase-chronic myeloid leukemia patients treated with first-generation tyrosine kinase inhibitors by Raghad Nabeel Abdul-Latif, Asaad A Khalaf, Adel S Aqabi

“…BACKGROUND: Chronic myelogenous leukemia is a hematological disorder of stem cells resulting from uncontrolled and unregulated growth of myeloid cells in the bone marrow. …”
Get full text

Outcome of Pregnancy in the Era of Pegylated Interferon Alpha 2a in Females with Essential Thrombocythemia: An Experience from Qatar by Mohammad Abu-Tineh, Nancy Kassem, Mohammad Abdul-Jaber Abdulla, Omar Mohammad Ismail, Rola Ghasoub, Mahmood B. Aldapt, Mohamed A. Yassin

“…All carry an increased risk to transform into acute leukemia or chronic myelogenous leukemia along with thrombosis and hemorrhagic complications. …”
Get full text

Summary of the published Indian data on chronic myeloid leukemia by Manish K Singhal, Manju Sengar, Reena Nair

“…Chronic myelogenous leukemia (LML) was recognized as a distinct entity in the mid-1800s. …”
Get full text

WT1 AND MULTIPLE MYELOMA: A POTENTIAL IMMUNOTHERAPEUTIC APPROACH FOR HAEMATOLOGICAL MALIGNANCIES by Ilaria Dulcamare

“…The Wilms’ tumour 1 (WT1) gene received particular attention in the last decades due to its role as oncogenic factors in acute myeloid leukemia, acute lymphocytic leukemia, chronic myelogenous leukemia and myelodysplastic syndromes, thus becoming an attractive target for immune therapy in such dismal diseases. …”
Get full text